Cover Image
市場調查報告書

EpiCast Report:過敏性鼻炎的流行病學預測

EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023

出版商 GlobalData 商品編碼 298495
出版日期 內容資訊 英文 50 Pages
訂單完成後即時交付
價格
Back to Top
EpiCast Report:過敏性鼻炎的流行病學預測 EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023
出版日期: 2014年04月30日 內容資訊: 英文 50 Pages
簡介

過敏性鼻炎是以鼻腔發炎為特徵的慢性呼吸器官疾病。全球主要7國(美國、法國、德國、義大利、西班牙、英國、日本)的過敏性鼻炎得病人數,預測將從2013年的1億2,327人,增加到2023年的1億2,542人。

本報告提供全球主要7個國家的過敏性鼻炎相關研究,提供危險因子的概要與全球趨勢,流行病學預測,流行病學報告,疾病趨勢分析,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 流行病學

  • 疾病的背景
  • 危險因子和共生病症
    • 家族病史,是兒童·成人過敏性鼻炎的強力預測因子
    • 暴露於環境的過敏誘發物質,會增加過敏性鼻炎的風險
    • 都市區的生活,提升了過敏性鼻炎的風險
    • 容易患得複數併發症
  • 全球的趨勢
    • 美國
    • EU5個國家
    • 日本
  • 預測手法
    • 利用之資訊來源
    • 未利用之資訊來源
    • 預測的前提條件與手法
  • 過敏性鼻炎的流行病學預測
    • 患病人數
    • 患病人數:各年齡
    • 患病人數:性別
    • 得病率:年齡標準化
    • 分佈:重症度別
    • 分佈:各類型
    • 特定的過敏誘發物質過敏反應
  • 議論
    • 流行病學預測相關考察
    • 分析的限制
    • 分析的優勢

第4章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Allergic rhinitis is a chronic respiratory disease characterized by inflammation of the nasal cavity and affects people of all ages. The main symptoms of allergic rhinitis are sneezing, nasal itching, blocked or runny nose and sore throat. Research suggests that a combination of genetic factors such as family history of allergic rhinitis and environmental factors such as exposure to allergens, including smoke, dust, pollen, insects, molds, or animal dander, may increase the risk for developing allergic rhinitis.

According to GlobalData's epidemiological forecast, the total prevalent cases of allergic rhinitis in the 7MM will increase from 123,273,876 total prevalent cases in 2013 to 125,427,387 total prevalent cases in 2023, at an annual growth rate of 0.17% during the forecast period.

In 2023, the US will have the highest number of the total prevalent cases of allergic rhinitis with 39,031,365 total prevalent cases, followed by Japan with 36,602,227 total prevalent cases.

To forecast the total prevalent cases of allergic rhinitis in the 7MM, GlobalData epidemiologists selected only nationally representative studies that provided total prevalence of allergic rhinitis using uniform diagnostic criteria based on self-reported prevalence of allergic rhinitis. The use of studies that provided uniform diagnostic criteria for total prevalence of allergic rhinitis facilitated meaningful comparison of the forecast total prevalent cases of allergic rhinitis across the 7MM. Furthermore, GlobalData epidemiologists provided a comprehensive forecast of the total prevalent cases of allergic rhinitis segmented by severity (mild, moderate, and severe) as well as type (seasonal, perennial, and both).

Scope

  • The Allergic Rhinitis EpiCast Report provide an overview of the risk factors, comorbidities, and the global and historical trends of allergic rhinitis in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast of the total prevalent cases of allergic rhinitis segmented by sex and age (ages =18 years).
  • The allergic rhinitis epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

  • Develop business strategies by understanding the trends shaping and driving the global allergic rhinitis market.
  • Quantify patient populations in the global allergic rhinitis market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for allergic rhinitis therapeutics in each of the markets covered.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports
  • 2.3. Upcoming Related Reports

3. Epidemiology

  • 3.1. Risk Factors and Comorbidities
    • 3.1.1. Family history of allergic rhinitis is a strong predictor for allergic rhinitis in children and adults
    • 3.1.2. Exposure to allergens in the environment increases the risk for allergic rhinitis
    • 3.1.3. Urban living elevates the risk of allergic rhinitis
    • 3.1.4. Comorbidities
  • 3.2. Global and Historical Trends
    • 3.2.1. US
    • 3.2.2. 5EU
    • 3.2.3. Japan
  • 3.3. Forecast Methodology
    • 3.3.1. Sources Used
    • 3.3.2. Sources Not Used
    • 3.3.3. Forecast Assumptions and Methods
  • 3.4. Epidemiological Forecast of Allergic Rhinitis (2013-2023)
    • 3.4.1. Total Prevalent Cases of Allergic Rhinitis
    • 3.4.2. Age-Specific Total Prevalent Cases of Allergic Rhinitis
    • 3.4.3. Sex-Specific Total Prevalent Cases of Allergic Rhinitis
    • 3.4.4. Age-Standardized Total Prevalence of Allergic Rhinitis
    • 3.4.5. Distribution of Total Prevalent Cases of Allergic Rhinitis by Severity
    • 3.4.6. Distribution of Total Prevalent Cases of Allergic Rhinitis by Type
    • 3.4.7. Allergic Rhinitis Total Prevalent Cases Sensitized to Specific Allergens
  • 3.5. Discussion
    • 3.5.1. Epidemiological Forecast Insight
    • 3.5.2. Limitations of the Analysis
    • 3.5.3. Strengths of the Analysis

4. Appendix

  • 4.1. Bibliography
  • 4.2. About the Authors
    • 4.2.1. Epidemiologists
    • 4.2.2. Reviewers
    • 4.2.3. Acting Director of Epidemiology
    • 4.2.4. Global Head of Healthcare
  • 4.3. About GlobalData
  • 4.4. About EpiCast
  • 4.5. Disclaimer

List of Tables

  • Table 1: Classification of Allergic Rhinitis
  • Table 2: Risk Factors and Comorbidities for Allergic Rhinitis
  • Table 3: Prevalence of Most Frequently Occurring Comorbidities in People with Allergic Rhinitis
  • Table 4: Age-Specific Prevalence of Hay Fever from the NHIS Survey in 2011
  • Table 5: Age- and Sex-Standardized Self-Reported Total Prevalence (%) of Allergic Rhinitis, Ages 20-44 Years, 5EU
  • Table 6: Total Prevalence (%) of Allergic Rhinitis in the EU, Ages 6-14 Years
  • Table 7: 7MM, Sources of Data Used for the Total Prevalence and the Segmentations for Allergic Rhinitis
  • Table 8: 7MM, Sources Excluded for the Epidemiological Forecast of Total Prevalent Cases of Allergic Rhinitis
  • Table 9: 7MM, Total Prevalent Cases of Allergic Rhinitis, Both Sexes, Ages ≥18 Years, N, 2013-2023
  • Table 10: 7MM, Age-Specific Total Prevalent Cases of Allergic Rhinitis, Both Sexes, N (Row %), 2013
  • Table 11: 7MM, Sex-Specific Total Prevalent Cases of Allergic Rhinitis, Ages ≥18 Years, N (Row %), 2013
  • Table 12: 7MM, Distribution of Total Prevalent Cases of Allergic Rhinitis by Severity, Both Sexes, N (Row %), 2013
  • Table 13: 7MM, Distribution of Total Prevalent Cases of Allergic Rhinitis by Type, Both Sexes, N (Row %), 2013
  • Table 14: 7MM, Proportion of Allergic Rhinitis Total Prevalent Cases Sensitized to Specific Allergens, Both Sexes, %, 2013

List of Figures

  • Figure 1: 7MM, Total Prevalent Cases of Allergic Rhinitis, Both Sexes, Ages ≥18 Years, N, 2013-2023
  • Figure 2: 7MM, Age-Specific Total Prevalent Cases of Allergic Rhinitis, Both Sexes, N, 2013
  • Figure 3: 7MM, Sex-Specific Total Prevalent Cases of Allergic Rhinitis, Ages ≥18 Years, N, 2013
  • Figure 4: 7MM, Age-Standardized Total Prevalence (%) of Allergic Rhinitis, Ages ≥18 Years, by Sex, 2013
Back to Top